SomaLogic, Inc.

CM Life Sciences II Acquisition Corp., listed under ticker CMII, was a life sciences-focused special purpose acquisition company sponsored by CM Life Sciences II Sponsor, LLC that completed its initial public offering in 2021. The SPAC targeted the healthcare and life sciences sectors and subsequently entered into a business combination with SomaLogic, Inc., a Boulder, Colorado-based proteomics company known for its SomaScan large-scale protein measurement platform. An S-1 registration statement was filed on October 1, 2021, covering securities issued in connection with the completed merger. Post-combination, SomaLogic traded on Nasdaq under the ticker SLGC. Sign up at SpacDesk for complete filing history, deal analytics, and real-time data on every SPAC transaction.